Previous studies have demonstrated that other kinase inhibitors such as Dasatinib could activate GSDME-mediated pyroptosis.18 Since Lenvatinib is also a kinase inhibitor, we hypothesized that it might induce pyroptosis in HCC cells through the activation of GSDME. Here, GSDME is linked to hepatocellular carcinoma.